1
CMN 548 – ADVANCED PSYCHOPHARMACOLOGY &
NEUROBIOLOGY EXAM WITH QUESTION AND
EXPLAINED ANSWERS/JUST RELEASED 2026
INSTANT FREE PDF
Thisexamtestsadvanced understandingof psychopharmacologyand neurobiology in clinical settin
w
q w
q w
q qw w
q qw w
q qw qw qw qw
gs. Key areas include:
qw qw qw
1. Neurotransmitters & Receptors qw qw
o Majorneurotransmitters(dopamine,serotonin,GABA,glutamate).
w
q w
q w
q w
q w
q
o Receptortypes (ionotropic vs.metabotropic, agonists vs. antagonists).
w
q qw qw w
q qw qw qw
2. Pharmacokinetics & Pharmacodynamics qw qw
o Absorption,distribution,metabolism,excretion(ADME). w
q w
q w
q w
q
o Dose-response curves, half-life, potency, efficacy. qw qw qw qw
3. Psychotropic Medications q w
o Antidepressants, antipsychotics, mood stabilizers, anxiolytics. qw qw qw qw
o Mechanisms, indications, sideeffects, and interactions. qw qw w
q qw qw
4. Neurobiology of Mental Disorders qw qw qw
o Biologicalbasesofdepression,anxiety,schizophrenia,bipolardisorder.
w
q w
q w
q w
q w
q w
q w
q
o Brainregionsinvolved(prefrontalcortex,amygdala,hippocampus).
w
q w
q w
q w
q w
q w
q
5. Clinical Applications qw
o Choosing medicationsbased on symptom profiles.
qw w
q qw qw qw
o Monitoring therapeutic responseand adverse effects.qw qw w
q qw qw
Tip: Focusonmechanismsofaction,receptorinteractions,neurotransmitterpathways,and clinical co
qw w
q w
q w
q w
q w
q w
q w
q w
q w
q qw qw
nsiderations.
,2
1. Whichneurotransmitterisprimarilyimplicatedinthe pa
w
q w
q w
q w
q w
q w
q qw
thophysiology of schizophrenia?qw qw
A. Dopamine
B. Serotonin
C. GABA
D. Acetylcholine
Answer:A w
q
Rationale:Dopaminedysregulation,particularlyhyperactivityinthe mesoli
w
q w
q w
q w
q w
q w
q qw
mbic pathway, is central to schizophrenia.
qw qw qw qw qw
2. SSRIsprimarilyincreasethesynapticavailabilityofwhich ne
qw w
q qw w
q w
q w
q qw qw
urotransmitter?
A. Serotonin
B. Dopamine
C. Norepinephrine
D. GABA
Answer:A w
q
Rationale:SSRIsblockserotoninreuptake,increasingserotonergic activity i
w
q w
q w
q w
q w
q w
q qw qw
n the synapse.
qw qw
,3
3. Whichreceptortypeisionotropic?
w
q w
q w
q w
q
A. NMDA
B. G-protein coupled serotonin receptor (5-HT1A)qw qw qw qw
C. DopamineD2 receptor w
q qw
D. Alpha-2 adrenergic receptor qw qw
Answer:A w
q
Rationale:Ionotropicreceptors(e.g.,NMDA)areligand-
w
q w
q w
q w
q w
q w
q
gatedion channels that mediate fast synaptic transmission.
w
q qw qw qw qw qw qw
4. Thehalf-lifeofadrugrefersto:
w
q w
q w
q w
q w
q w
q
A. Thetimeittakesforplasmaconcentrationtodecreaseby50%
w
q w
q w
q w
q w
q w
q w
q w
q w
q w
q
B. Thetime toreach peak effect
w
q qw qw qw qw
C. Thetimeuntilthe drugis completely excreted
w
q qw w
q qw w
q qw qw
D. Thedurationoftherapeuticeffect
w
q w
q w
q w
q
Answer:A w
q
Rationale: Half- qw
lifemeasuresthetimeneededfordrug plasmalevelsto fall by half.
w
q w
q w
q qw w
q w
q qw w
q w
q qw qw qw
5. Benzodiazepinesexerttheireffectby: w
q qw w
q qw
A. Enhancing GABA-A receptor activity qw qw qw
B. Blockingdopaminereceptors w
q w
q
C. Inhibitingserotoninreuptake w
q w
q
D. Activating NMDA receptors qw qw
Answer:A w
q
Rationale:BenzodiazepinespotentiateGABA-
w
q w
q w
q
mediatedchlorideinflux, causing CNS inhibition.
w
q w
q qw qw qw
, 4
6. Lithium’stherapeuticeffectinbipolardisorderisprimarilythrough:
w
q w
q w
q w
q w
q w
q w
q w
q
A. Modulation of intracellular signaling and neurotransmitter balance
qw qw qw qw qw qw
B. DopamineD2receptorblockade w
q w
q w
q
C. GABA-A receptorenhancement
qw qw
D. Serotoninreuptakeinhibition w
q qw
Answer:A w
q
Rationale:Lithiummodulatessecondmessengersystemsandstabilizes neu
w
q w
q w
q qw w
q w
q w
q qw
ronal signaling.
qw
7. Clozapineisclassifiedasa: w
q w
q w
q w
q
A. Atypical antipsychotic qw
B. Typicalantipsychotic
w
q
C. SSRI
D. Moodstabilizer
w
q
Answer:A w
q
Rationale:Clozapineisanatypicalantipsychoticwithhighefficacyfor trea
w
q w
q w
q w
q w
q w
q w
q w
q w
q qw
tment-resistant schizophrenia. qw
8. WhichneurotransmitterisprimarilyinhibitoryintheCNS?
w
q w
q w
q w
q w
q w
q w
q
A. GABA
B. Glutamate
C. Dopamine
D. Acetylcholine
CMN 548 – ADVANCED PSYCHOPHARMACOLOGY &
NEUROBIOLOGY EXAM WITH QUESTION AND
EXPLAINED ANSWERS/JUST RELEASED 2026
INSTANT FREE PDF
Thisexamtestsadvanced understandingof psychopharmacologyand neurobiology in clinical settin
w
q w
q w
q qw w
q qw w
q qw qw qw qw
gs. Key areas include:
qw qw qw
1. Neurotransmitters & Receptors qw qw
o Majorneurotransmitters(dopamine,serotonin,GABA,glutamate).
w
q w
q w
q w
q w
q
o Receptortypes (ionotropic vs.metabotropic, agonists vs. antagonists).
w
q qw qw w
q qw qw qw
2. Pharmacokinetics & Pharmacodynamics qw qw
o Absorption,distribution,metabolism,excretion(ADME). w
q w
q w
q w
q
o Dose-response curves, half-life, potency, efficacy. qw qw qw qw
3. Psychotropic Medications q w
o Antidepressants, antipsychotics, mood stabilizers, anxiolytics. qw qw qw qw
o Mechanisms, indications, sideeffects, and interactions. qw qw w
q qw qw
4. Neurobiology of Mental Disorders qw qw qw
o Biologicalbasesofdepression,anxiety,schizophrenia,bipolardisorder.
w
q w
q w
q w
q w
q w
q w
q
o Brainregionsinvolved(prefrontalcortex,amygdala,hippocampus).
w
q w
q w
q w
q w
q w
q
5. Clinical Applications qw
o Choosing medicationsbased on symptom profiles.
qw w
q qw qw qw
o Monitoring therapeutic responseand adverse effects.qw qw w
q qw qw
Tip: Focusonmechanismsofaction,receptorinteractions,neurotransmitterpathways,and clinical co
qw w
q w
q w
q w
q w
q w
q w
q w
q w
q qw qw
nsiderations.
,2
1. Whichneurotransmitterisprimarilyimplicatedinthe pa
w
q w
q w
q w
q w
q w
q qw
thophysiology of schizophrenia?qw qw
A. Dopamine
B. Serotonin
C. GABA
D. Acetylcholine
Answer:A w
q
Rationale:Dopaminedysregulation,particularlyhyperactivityinthe mesoli
w
q w
q w
q w
q w
q w
q qw
mbic pathway, is central to schizophrenia.
qw qw qw qw qw
2. SSRIsprimarilyincreasethesynapticavailabilityofwhich ne
qw w
q qw w
q w
q w
q qw qw
urotransmitter?
A. Serotonin
B. Dopamine
C. Norepinephrine
D. GABA
Answer:A w
q
Rationale:SSRIsblockserotoninreuptake,increasingserotonergic activity i
w
q w
q w
q w
q w
q w
q qw qw
n the synapse.
qw qw
,3
3. Whichreceptortypeisionotropic?
w
q w
q w
q w
q
A. NMDA
B. G-protein coupled serotonin receptor (5-HT1A)qw qw qw qw
C. DopamineD2 receptor w
q qw
D. Alpha-2 adrenergic receptor qw qw
Answer:A w
q
Rationale:Ionotropicreceptors(e.g.,NMDA)areligand-
w
q w
q w
q w
q w
q w
q
gatedion channels that mediate fast synaptic transmission.
w
q qw qw qw qw qw qw
4. Thehalf-lifeofadrugrefersto:
w
q w
q w
q w
q w
q w
q
A. Thetimeittakesforplasmaconcentrationtodecreaseby50%
w
q w
q w
q w
q w
q w
q w
q w
q w
q w
q
B. Thetime toreach peak effect
w
q qw qw qw qw
C. Thetimeuntilthe drugis completely excreted
w
q qw w
q qw w
q qw qw
D. Thedurationoftherapeuticeffect
w
q w
q w
q w
q
Answer:A w
q
Rationale: Half- qw
lifemeasuresthetimeneededfordrug plasmalevelsto fall by half.
w
q w
q w
q qw w
q w
q qw w
q w
q qw qw qw
5. Benzodiazepinesexerttheireffectby: w
q qw w
q qw
A. Enhancing GABA-A receptor activity qw qw qw
B. Blockingdopaminereceptors w
q w
q
C. Inhibitingserotoninreuptake w
q w
q
D. Activating NMDA receptors qw qw
Answer:A w
q
Rationale:BenzodiazepinespotentiateGABA-
w
q w
q w
q
mediatedchlorideinflux, causing CNS inhibition.
w
q w
q qw qw qw
, 4
6. Lithium’stherapeuticeffectinbipolardisorderisprimarilythrough:
w
q w
q w
q w
q w
q w
q w
q w
q
A. Modulation of intracellular signaling and neurotransmitter balance
qw qw qw qw qw qw
B. DopamineD2receptorblockade w
q w
q w
q
C. GABA-A receptorenhancement
qw qw
D. Serotoninreuptakeinhibition w
q qw
Answer:A w
q
Rationale:Lithiummodulatessecondmessengersystemsandstabilizes neu
w
q w
q w
q qw w
q w
q w
q qw
ronal signaling.
qw
7. Clozapineisclassifiedasa: w
q w
q w
q w
q
A. Atypical antipsychotic qw
B. Typicalantipsychotic
w
q
C. SSRI
D. Moodstabilizer
w
q
Answer:A w
q
Rationale:Clozapineisanatypicalantipsychoticwithhighefficacyfor trea
w
q w
q w
q w
q w
q w
q w
q w
q w
q qw
tment-resistant schizophrenia. qw
8. WhichneurotransmitterisprimarilyinhibitoryintheCNS?
w
q w
q w
q w
q w
q w
q w
q
A. GABA
B. Glutamate
C. Dopamine
D. Acetylcholine